Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

March 19, 2019

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Chronic Prostatitis With Chronic Pelvic Pain SyndromeErectile Dysfunction
Interventions
DRUG

Sildenafil

Subjects were given sildenafil citrate, 25mg/capsule, once a night, one capsule each time, for 4 weeks.

DRUG

Ningmitai capsule

The subjects took Ningmitai capsule, 0.38 g/capsule, 3 times a day, 4 capsules each time, after meals, and continued to treat for 4 weeks.

DRUG

Ningbitai capsule + sildenafil

The subjects took Ningmitai capsule orally, 0.38 g/capsule, 3 times a day, 4 capsules each time, and took it after meals. Sildenafil citrate, 25mg/capsule, once a night, one capsule each time, was taken orally for 4 weeks.

Trial Locations (1)

671013

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Xintian Pharmaceutical

INDUSTRY

NCT06064448 - Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction | Biotech Hunter | Biotech Hunter